83 related articles for article (PubMed ID: 4423932)
1. The role of immunological factors in viral and oncogenic processes. Introduction.
Beers RF
Johns Hopkins Med J Suppl; 1974; 3():xxi-xxii. PubMed ID: 4423932
[No Abstract] [Full Text] [Related]
2. Low-dose naltrexone for disease prevention and quality of life.
Brown N; Panksepp J
Med Hypotheses; 2009 Mar; 72(3):333-7. PubMed ID: 19041189
[TBL] [Abstract][Full Text] [Related]
3. Progress in human tumour immunology and immunotherapy.
Rosenberg SA
Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
[TBL] [Abstract][Full Text] [Related]
4. The spontaneous regression of neoplasms in mammals: possible mechanisms and their application in immunotherapy.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1998; 12(1):107-22. PubMed ID: 9575433
[TBL] [Abstract][Full Text] [Related]
5. New approaches to immunoprevention and immunotherapy of neoplasms.
Glushkov AN
Russ J Immunol; 2002 Oct; 7(3):219-28. PubMed ID: 12674931
[TBL] [Abstract][Full Text] [Related]
6. MUC1 as a target antigen for cancer immunotherapy.
Acres B; Limacher JM
Expert Rev Vaccines; 2005 Aug; 4(4):493-502. PubMed ID: 16117706
[TBL] [Abstract][Full Text] [Related]
7. Cancer.
Curr Opin Immunol; 1993 Oct; 5(5):805-35. PubMed ID: 8240744
[No Abstract] [Full Text] [Related]
8. Proceedings: Progress in cancer research, diagnosis and treatment.
Clark RL
Proc Natl Cancer Conf; 1972; 7():11-5. PubMed ID: 4587644
[No Abstract] [Full Text] [Related]
9. [Oncology 1999: advances in immunotherapy].
Cerny T
Schweiz Med Wochenschr; 2000 Jan; 130(1-2):21-4. PubMed ID: 10670041
[No Abstract] [Full Text] [Related]
10. Natural and acquired immunity to cancer.
Hadley HG
J Indiana State Med Assoc; 1968 Apr; 61(4):464-6. PubMed ID: 5655138
[No Abstract] [Full Text] [Related]
11. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
12. Tumour immunology.
Mitchison NA
Essays Fundam Immunol; 1973; 0(1):57-66. PubMed ID: 4547342
[No Abstract] [Full Text] [Related]
13. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
[TBL] [Abstract][Full Text] [Related]
14. Horizons in tumor immunology.
Morton DL
Surgery; 1973 Jul; 74(1):69-79. PubMed ID: 4715884
[No Abstract] [Full Text] [Related]
15. [Tumors and immunity].
Balducci D
Recenti Prog Med; 1968 Jul; 45(1):7-22. PubMed ID: 5755423
[No Abstract] [Full Text] [Related]
16. [Problems of tumor immunology and immunotherapy].
Schmidt CG
Helv Chir Acta; 1973 Mar; 40(1):77-86. PubMed ID: 4540691
[No Abstract] [Full Text] [Related]
17. Immune recognition of malignancies: relevance to immunotherapy.
Nabel GJ
Cancer J Sci Am; 1998 May; 4 Suppl 1():S106-11. PubMed ID: 9619279
[No Abstract] [Full Text] [Related]
18. [Induction of specific antitumor immunity in hamsters with green marmoset virus SA7(C8)].
Babakova SV; Dodonova NN; Tsetlin EM; Gorodilova VV; Ageenko AI; Al'tshteĭn AD
Vopr Onkol; 1970; 16(3):40-6. PubMed ID: 5419649
[No Abstract] [Full Text] [Related]
19. [Immune tolerance and active suppression in oncology. Immunological principles and therapeutic options].
Stremmel C; Klein P; Hohenberger W
Chirurg; 2002 Mar; 73(3):255-61. PubMed ID: 11963500
[TBL] [Abstract][Full Text] [Related]
20. Crabshoot. Manufacturers gamble on cancer vaccines--again.
Beardsley T
Sci Am; 1994 Sep; 271(3):102. PubMed ID: 8091184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
